Judge Approves $150M Flonase Antitrust Accord

Law360, Miami (June 14, 2013, 6:57 PM EDT) -- A Pennsylvania federal judge on Friday approved a $150 million settlement, including $50 million in attorneys' fees, ending a direct purchaser antitrust class action accusing GlaxoSmithKline of filing sham petitions with federal authorities to delay generic alternatives to Flonase nasal spray.

U.S. Federal Judge Anita B. Brody signed off on the deal with the class of direct purchasers, led by Meijer Inc. and American Sales Co., that was hammered out in December. Indirect purchaser plaintiffs also have asked for approval of a $45 million class action...
To view the full article, register now.